Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF

Bone Marrow Transplant. 2012 Jul;47(7):1003-5. doi: 10.1038/bmt.2011.199. Epub 2011 Oct 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Benzylamines
  • Body Mass Index
  • Contraindications
  • Cyclams
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Hematopoietic Stem Cell Mobilization / methods*
  • Heterocyclic Compounds / administration & dosage*
  • Hodgkin Disease / pathology
  • Humans
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Middle Aged
  • Multiple Myeloma / pathology
  • Obesity / physiopathology
  • Overweight / physiopathology
  • Retrospective Studies
  • Thinness / physiopathology
  • Young Adult

Substances

  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • Granulocyte Colony-Stimulating Factor
  • plerixafor